Oncolytics Biotech (ONC) Competitors C$0.77 -0.01 (-1.28%) As of 04/17/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock ONC vs. BCT, APS, IPA, FRX, SCYB, COM, NVH, IGX, TH, and MDNAShould you be buying Oncolytics Biotech stock or one of its competitors? The main competitors of Oncolytics Biotech include BriaCell Therapeutics (BCT), Aptose Biosciences (APS), ImmunoPrecise Antibodies (IPA), Fennec Pharmaceuticals (FRX), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), IntelGenx Technologies (IGX), Theratechnologies (TH), and Medicenna Therapeutics (MDNA). These companies are all part of the "biotechnology" industry. Oncolytics Biotech vs. BriaCell Therapeutics Aptose Biosciences ImmunoPrecise Antibodies Fennec Pharmaceuticals Scythian Biosciences 138267 (COM.TO) Novoheart IntelGenx Technologies Theratechnologies Medicenna Therapeutics Oncolytics Biotech (TSE:ONC) and BriaCell Therapeutics (CVE:BCT) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, community ranking, earnings, profitability, institutional ownership, dividends and risk. Does the MarketBeat Community favor ONC or BCT? Oncolytics Biotech received 156 more outperform votes than BriaCell Therapeutics when rated by MarketBeat users. Likewise, 74.81% of users gave Oncolytics Biotech an outperform vote while only 68.97% of users gave BriaCell Therapeutics an outperform vote. CompanyUnderperformOutperformOncolytics BiotechOutperform Votes19674.81% Underperform Votes6625.19% BriaCell TherapeuticsOutperform Votes4068.97% Underperform Votes1831.03% Do institutionals and insiders believe in ONC or BCT? 1.8% of Oncolytics Biotech shares are held by institutional investors. 3.8% of Oncolytics Biotech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media favor ONC or BCT? In the previous week, BriaCell Therapeutics had 1 more articles in the media than Oncolytics Biotech. MarketBeat recorded 2 mentions for BriaCell Therapeutics and 1 mentions for Oncolytics Biotech. Oncolytics Biotech's average media sentiment score of 0.55 beat BriaCell Therapeutics' score of -0.66 indicating that Oncolytics Biotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oncolytics Biotech 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BriaCell Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Negative Which has higher valuation & earnings, ONC or BCT? BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Oncolytics Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOncolytics BiotechN/AN/A-C$27.66M-C$0.36-2.15BriaCell TherapeuticsN/AN/AN/A-C$0.38-28.19 Is ONC or BCT more profitable? BriaCell Therapeutics' return on equity of 0.00% beat Oncolytics Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Oncolytics BiotechN/A -141.94% -71.33% BriaCell Therapeutics N/A N/A N/A SummaryOncolytics Biotech beats BriaCell Therapeutics on 7 of the 10 factors compared between the two stocks. Get Oncolytics Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONC vs. The Competition Export to ExcelMetricOncolytics BiotechBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$59.35MC$121.10MC$5.31BC$5.53BDividend Yield0.31%3.75%5.45%6.44%P/E Ratio-2.153.0521.8829.92Price / SalesN/A4,230.36380.66583.88Price / Cash4.2213.1938.2683.35Price / Book6.5534.276.453.53Net Income-C$27.66M-C$91.73MC$3.22BC$300.83M1 Month Performance-13.48%-5.02%-9.75%-3.71%1 Year Performance-46.53%84.04%11.50%11.14% Oncolytics Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONCOncolytics Biotech0.4519 of 5 starsC$0.77-1.3%C$3.50+354.5%-46.5%C$59.35MN/A-2.1529Gap UpBCTBriaCell TherapeuticsN/AC$10.60-3.8%C$15.00+41.5%+0.0%C$168.68MN/A-28.195APSAptose BiosciencesN/AC$3.85-19.8%N/A-93.5%C$165.77MN/A-0.7731Gap UpHigh Trading VolumeIPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownFRXFennec PharmaceuticalsN/AC$7.58+1.7%N/A-44.8%C$146.18MC$34.86M-128.4010Gap DownSCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/AN/AC$102.19MN/A0.00N/ANVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423,500.00-13.95N/AIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap UpTHTheratechnologiesN/AC$2.35+6.8%N/A+92.3%C$74.98MC$52.22M-26.60103Analyst RevisionNews CoverageGap DownMDNAMedicenna TherapeuticsN/AC$0.93+3.3%N/A-32.9%C$69.58MC$4,868.39-2.5620Gap Down Related Companies and Tools Related Companies BriaCell Therapeutics Alternatives Aptose Biosciences Alternatives ImmunoPrecise Antibodies Alternatives Fennec Pharmaceuticals Alternatives Scythian Biosciences Alternatives 138267 (COM.TO) Alternatives Novoheart Alternatives IntelGenx Technologies Alternatives Theratechnologies Alternatives Medicenna Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:ONC) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncolytics Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncolytics Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ONC Stock Free ONC Stock Alerts